Bifocal soft contact lenses as a possible myopia control treatment: a case report involving identical twins

Abstract

Background:  Several studies have suggested that bifocal and progressive spectacles can reduce progression of myopia in esophoric children. This study compared myopic progression with bifocal (BSCL) and single vision soft contact lenses (SVSCL) in identical twins with near point esophoria.

Methods:  Two 12‐year‐old myopic girls were randomly assigned to wear either BSCL or SVSCL for one year using a double‐masked design. Both twins then wore BSCLs for another year. Ocular measurements included cycloplegic and manifest refractions, corneal curvature and axial length. Distance and near phorias were measured through distance corrections and near associated phorias, with both types of contact lenses.

Results:  Through their SVSCLs, both children exhibited near associated esophorias, which were neutralised by the BSCLs. The child wearing SVSCLs over the first year showed significant myopic progression, increasing ‐1.19-D (binocular average), while the child wearing BSCLs showed no progression (+0.13-D). The latter child showed limited progression (‐0.28-D) over the second year, while switching from SVSCLs to BSCLs arrested progression in the other child (+0.44-D after one year). Axial length data were consistent with the refractive findings; the child exhibiting more myopia at the end of the first 12 months of the study had longer eyes (by 0.64-mm) than her sister, although their corneas also had steepened more (by 0.44-D compared to 0.18-D). The children showed similar, small increases in eye size over the second year when both wore BSCLs (binocular averages: 0.05, 0.09-mm, respectively).

Conclusion:  The apparent inhibitory effect of BSCLs on myopic progression reported in this twin study argues for further study of their efficacy as a control treatment for myopes with near esophoria.

Key words:

• accommodation
• children's vision
• contact lenses
• myopia

View correction statement:

Erratum

ACKNOWLEDGEMENTS

Lenses were provided by Johnson & Johnson Vision Care Inc. Solutions were provided by Alcon Laboratories Inc.